- Lamisil AT
Treatment of a variety of cutaneous fungal infections, including tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm).
Affects the synthesis of the fungal cell wall.
Decrease in symptoms of fungal infection.
Absorption: Absorption through intact skin is minimal.
Distribution: Distribution after topical administration is primarily local.
Metabolism and Excretion: Highly metabolized; excreted in urine (primarily as metabolites).
Half-life: 21 hr.
- Hypersensitivity to active ingredients, additives, preservatives, or bases
- Some products contain alcohol and should be avoided in patients with known intolerance.
Use Cautiously in:
- Nail and scalp infections (may require additional systemic therapy)
- OB: Lactation: Safety not established.
Adverse Reactions/Side Effects
Local: burning, itching, local hypersensitivity reactions, redness, stinging
* CAPITALS indicate life-threatening.
Underline indicate most frequent.
Topical (Adults and Children ≥12 yr): Apply twice daily for 1 wk for tinea pedis. Apply once daily for 1 wk for tinea cruris or tinea corporis.
Availability (generic available)
Spray liquid: 1%
- Inspect involved areas of skin and mucous membranes before and frequently during therapy. Increased skin irritation may indicate need to discontinue medication.
- Consult physician or other health care professional for proper cleansing technique before applying medication.
- Topical Apply small amount to cover affected area completely. Avoid the use of occlusive wrappings or dressings unless directed by physician or other health care professional.
- Instruct patient to apply medication as directed for full course of therapy, even if feeling better. Emphasize the importance of avoiding the eyes.
- Caution patient that some products may stain fabric, skin, or hair. Check label information. Fabrics stained from cream can usually be cleaned by handwashing with soap and warm water.
- Patients with athlete's foot should be taught to wear well-fitting, ventilated shoes, to wash affected areas thoroughly, and to change shoes and socks at least once a day.
- Advise patient to report increased skin irritation or lack of response to therapy to health care professional.
Decrease in skin irritation and resolution of infection. Early relief of symptoms may be seen in 2–3 days.
Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drugs, procedures, and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and PRIME Journals. Complete Product Information.